Because of the COVID-19 pandemic, we prefer to hold all our meetings currently via video or phone conferences. However all our laboratory services are alive and can be used.
We are actively working with national and international partners to create better therapies and nutrition-based preventive possibilities for decreasing infections and ameliorating  moderate COVID symptoms. 
Post-COVID autoimmune disorders will mean a great burden for all societies so we have initiated an in-house program in this field. All partners and interested scientists are invited to join.
We are also proud to be members of the team that produced the first direct images of the native SARS-CoV-2 virion:

As environmental isotopic imaging measurements are important to us, CROmed proudly sponsors the TREICEP Conference in Veszprém, 22-25 May 2018.

CROmed takes part and has oral and poster presentations at the PSMR 2018 Conference in Italy, 21-23 May 2018.

CROmed takes part in EANM 2016 in Barcelona, 15-19 October 2016.

CROmed is delivering a Continuing Medical Education presentation on Multimodal Imaging in Drug Development during the European Association of Nuclear Medicine’s Current Congress in Hamburg, 10-14 October 2015.

CROmed takes part in ICCU 2015 Meeting in Lisboa, 10-12 April 2015.

CROmed takes part and has poster presentations on 10th European Molecular Imaging Meeting 18-20 March 2015, Tubingen, Germany.

  1. Detection of microscopic metastatic liver disease in a mouse model using inhomogeneity parameters in particle-based liver SPECT imaging
  2. Early effects of systemic inflammation on brain injury and peripheral organs after cerebral ischemia

CROmed takes part in InMind Meeting in Bonn, 26-27 February 2015.

CROmed takes part in WMIC 2014, Seoul, Korea 17-20 September 2014.

CROmed has poster presentation in the Congress of World Federation of Nuclear Medicine and Biology, Cancun, Mexico, 27-31 August, 2014.

Preclinical SPECT liver study of tumour caused inhomogenous activity distribution characterised by simple parameters

CROmed has three poster presentations in Joint Meeting of the Federation of European Physiological Society and the Hungarian Physiological Society Budapest Hungary 27-30 August 2014:

  1. The effects of body mass on MRgluc-related metabolic activity in mouse joints investigated by in vivo dynamic PET/MRI
  2. In vivo imaging of brain after cerebral ischaemia using SPECT/CT in mice
  3. How to use PET/MRI to observe metabolic and cellular effects of portal vein ligation in healthy rat liver

CROmed takes part in BIO-Convention as Hungarian Exhibitor. Please do not forget meet us in San Diego, CA, USA 23-26 June, 2014. You can also rend us meeting request.

CROmed has two poster presentations in 9th European Molecular Imaging Meeting, 4-6 June, 2014, Antwerpen, Belgium:

  1. Production and SPECT/CT in-vivo mouse biodistribution of 203Pb-chloride as surrogate dosimetric isotope in 212Pb/212Bi alpha-therapy
  2. Synthesis and in-vivo use of tri-modality core-shell nanoparticles with PET, MRI and fluorescence signals

CROmed has poster presentation in 82nd European Atherosclerosis Society Congress, 31 May-3 June, Madrid, Spain: Role of In Vivo Imaging of Cardiovascular Research, Diagnosis and Treatment.

CROmed is proudly sponsoring Neuroreceptor Mapping 2014, Amsterdam Neuroscience and PET/SPECT/MR synergistic-please come to Amsterdam and see for yourself. Amsterdam, The Netherlands 21-24 May, 2014.

CROmed participates in XIII Turku PET Symposium with an oral presentation and several posters, Finland 24 – 27 May, 2014.

We are among the first groups in multimodal PET/MRI contrast agent applications. We know bimodal tracers provide greatly increased biologic sensitivity and one-step internally validated results.

So we are proud to support PSMR 2014, the leading world event in the field of PET/MRI applications of multimodal contrast agents. Kos, Greece, 19-21 May, 2014.
On PSMR 2014 CROmed has two oral presentations:

  1. Proof-of-principle study with 68 Ga/ Gd labelled PET/MRI imaging probe for pH assessment.
  2. Simple radiolabelling of inorganic core-shell nanoparticles for multimodality imaging.

CROmed participates on Odense Spring Meeting with an oral presentation about a new radiolabeled antibiotic to image tuberculosis. Odense, Denmark 12-14 May 2014

CROmed presents poster in Stem Cell Summit 2014 Cambridge, USA, 23-25 April 2014

CROmed takes part in the International Conference on Radiopharmacy and Radiopharmaceutils in March: Madrid, 27-28 March 2014.

CROmed takes part in NuklearMedizin Congress in Hannover, Germany 26-29 March 2014

CROmed takes part in BioSpring Europe, Torino, Italy, 10-12 March, 2014

CROmed has a poster presentation on 6th International Conference on Drug Discovery and Therapy, Dubai, 10-12 February 2014 Poster # 63

Advances and Applications for Positron Emission Tomography-Magnetic Resonance Hybrid Imaging
Meet us in Dubai and get more about our exciting results.

CROmed has a poster on IBRO Workshop 2014, Debrecen, Hungary 16-17 January 2014
Quantitative In Vivo Imaging in Brain Research

CROmed has an oral presentation on the Congress of the Hungarian Experimental and Clinical Pharmacologist Association 2013 event, Debrecen, Hungary 12-14 December 2013.

CROmed continues obtaining Quality Nano Transnational Access grants
for 2014 with the Joint Research Centre in the field of radiolabeled industrial nanoparticle studies.

CROmed takes part at Bio Europe Vienna (November 4-6)
Find us at the Hungarian booth, and let’s make a conversation about your ideas.

CROmed has a presentation on the Symposium on the First Preclinical Nuclear Imaging on 4th November
In vivo kinetic brain mapping of 18F-FDDNP non-specific binding for transgenic mouse models of Alzheimer’s Disease.

CROmed takes part at the Protein Discovery Summit in San Diego
Find us and tell your ideas in San Diego from 23-25 October 2013.

Meet with CROmed at the EANM’13 Annual Congress (October 19 – 23, 2013 in Lyon/FRANCE)
EANM’13 – Annual Congress of the European Association of Nuclear Medicine
We have posters and oral presentation:
PET/MRI/SPECT/CT in vivo longitudinal imaging of Earthworm (Lumbricus terrestris L.),
as a novel aspect for toxicological testing Poster #P494
The Role of Acetyl-L-Carnitine in the Mice Brain Glucose Uptake Poster #PW050
Oral presentations:
Cyclotron activated nanoparticles: application in PET/SPECT imaging
Metabolic PET/CT investigations on shellfish: biomarker feasibility of important environmental sentinel organisms

Let’s meet with us at Drug Discovery Week Europe: (October 9-10, Berlin)

CROmed has a poster presentation in Savannah at the WMIC 2013
World Molecular Imaging Congress 2013 in (September 18-21 – Savannah, Georgia)
Oral Presentation:
In vivo basic tracer pharmacokinetic analysis for transgenic mouse
models of Alzheimer’s disease: #1700327

CROmed attended at Neurodegenerative Conditions Research and Development Conference – September 9-10, Boston

BioForum 2013
Meet us in our hometown. Budapest hosts the BioForum, the leading Central European bio event and CROmed has a booth there.

EMIM 2013
CROmed will present one oral paper and two posters at the European Molecular Imaging Meeting in Torino, 26-28 May 2013. An invited talk about multi-modal probes in the Focus series is also foreseen at EMIM by us.

SNMMI 2013
CROmed will be there in Vancouver for the Society of Nuclear Medicine and Molecular Imaging annual congress 8-11 June 2013. To schedule a meeting please contact us

Meet CROmed in Chicago
at BIO International Convention 22-25 April 2013. Please visit us at the booth #0610 and share your ideas with us

Meet us in Barcelona
on the event Bio-Spring Europe 11-13 March 2013

Successful R&I in Europe
CROmed has a presentation on the event Successful R&I in Europe, in Düsseldorf 7-8 March 2013.

Meet us at EANM 2012, Milan
CROmed makes three oral presentations and two posters at the European Association of Nuclear Medicine 2012 Annual Conference in Milan, Italy.
Presentation #OP364 presents a novel model for radiopharmaceutical investigators and #OP523 deals with quantitative SPECT by monitoring liver lesions in mouse.
Presentation #OP670 presents a small animal PET/MR System.
Poster #P0089 deals with evaluation of 177Lu-nimotuzumab for targeted radioimmunotherapy of EGFR expressing tumors, and poster # PW030 presents a PET/MRI study by [11C]raclopride in rat.

CROmed is mentioned on the title page on the homepage of WMIC and also on the homepage of WMIS connected with SPECT/MRI

WMIC 2012, Dublin
CROmed presented five posters at the World Molecular Imaging Conference 2012 in Dublin, Ireland.

Meet us at SNM
CROmed will be attending the 2012 SNM congress in Miami. To schedule a meeting between 10 and 13 June, please contact us at office[at]cromedresearch[dot]com.

European Symposium of Radiochemistry and Radiopharmacy 2012 Nantes
CROmed will deliver an Expert Panel talk on small animal images in drug development at the ESRR 2012 conference in Nantes, France in the Saturday, 28 April Drug Development Panel

CROmed has won a Joint Research Centre Transnational Access grant to continue scientific work in the field of radiolabeled nanoparticles

Imaging in Drug Discovery & Development, WPC2011, Philadelphia
CROmed exhibited a poster about our company at the World Pharma Congress

JSNM 2011, Tsukuba
CROmed has presented the use of PET/MRI imaging technology in rodents in two oral presentations at the 51st Conference of Japanese Nuclear Medicine Society in Tsukuba, Japan, 27-29 October 2011.

EANM 2011, Birmingham
CROmed makes two oral presentations at the European Association of Nuclear Medicine 2011 Annual Conference in Birmingham, UK.
Presentation #OP268 presents our proprietary SPECT/PET-MRI nanoparticle contrast agent technology and #OP273 deals with Cannabinoid-1 receptor imaging in the CNS offered by us.

WMIC 2011, San Diego
CROmed presents three posters at the World Molecular Imaging Conference 2011 in San Diego, CA, USA

World Pharma Congress 2011
The Zooming In Concept poster